Indiplon
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 66 (Table of Contents)
Published: 5 Dec-2005
DOI: 10.3833/pdr.v2005.i66.594 ISSN: 1756-7874
Section: Deal Trackers
Fulltext:
Abstract
Indiplon is a second-generation sedative hypnotic – a nonbenzodiazepine GABA-A receptor agonist selective for the alpha-1 subunit – that is being developed by Neurocrine Biosciences for the treatment of insomnia, both as an immediate-release (IR) capsule and a modified-release (MR) tablet...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS